Daiwa Securities Group Inc. Has $1 Million Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Daiwa Securities Group Inc. lowered its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 4.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 70,297 shares of the real estate investment trust’s stock after selling 3,526 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Sabra Health Care REIT were worth $1,003,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. GraniteShares Advisors LLC acquired a new position in shares of Sabra Health Care REIT in the 4th quarter valued at $1,455,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Sabra Health Care REIT by 4.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 89,060 shares of the real estate investment trust’s stock worth $1,271,000 after buying an additional 3,633 shares during the period. Mackenzie Financial Corp raised its stake in Sabra Health Care REIT by 113.3% during the 4th quarter. Mackenzie Financial Corp now owns 32,483 shares of the real estate investment trust’s stock worth $464,000 after buying an additional 17,256 shares during the period. Strs Ohio raised its stake in Sabra Health Care REIT by 104.1% during the 4th quarter. Strs Ohio now owns 100,000 shares of the real estate investment trust’s stock worth $1,427,000 after buying an additional 51,000 shares during the period. Finally, Louisiana State Employees Retirement System acquired a new stake in Sabra Health Care REIT during the 4th quarter worth $926,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on SBRA shares. Deutsche Bank Aktiengesellschaft started coverage on Sabra Health Care REIT in a research note on Tuesday, January 30th. They set a “buy” rating and a $21.00 price objective on the stock. Wedbush reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Finally, Mizuho raised their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $15.54.

Sabra Health Care REIT Stock Performance

SBRA opened at $13.70 on Thursday. The business’s 50-day moving average price is $14.06 and its two-hundred day moving average price is $14.04. Sabra Health Care REIT, Inc. has a 1 year low of $10.30 and a 1 year high of $14.91. The company has a market capitalization of $3.17 billion, a price-to-earnings ratio of 274.00, a P/E/G ratio of 4.95 and a beta of 1.16. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.41 and a quick ratio of 3.41.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Tuesday, February 13th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 8.76%. The ex-dividend date was Monday, February 12th. Sabra Health Care REIT’s payout ratio is 2,400.00%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.